Our aim was to assess the association of SLC22A9 genetic variants with bone quality, fracture risk and serum bone turnover markers in a cross-sectional population-based cohort study from Germany (SHIP) (15), which had been previously used to identify fracture risk and risk factors for osteoporosis (16). Here, SLC22A9 is linked to osteoporosis.